-The Economic Times   The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

-The Times of India Instead of creating happiness in the lives of farmers in adjacent villages, Adani power corporation has rendered them landless as their agricultural land is forcibly acquired by the district administration for requirement of the thermal power company. Once affluent, these farmers have now come below poverty line. Adani Thermal Power Corporation has acquired agricultural land in and around it's thermal power plant near Tiroda (Gondia). The state government gave...

The apex decision-making body of the communications ministry has cleared the proposal to grant more powers to the Telecom Regulatory Authority of India (TRAI) and enable the watchdog to act like a civil court.  This puts TRAI on par with the Securities and Exchange Board of India and the Competition Commission of India and permits the telecom regulator to 'summon persons, examine them on oath, demand documents and evidence on affidavits...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...